Increased albumin and fibrinogen synthesis rate in patients with chronic renal failure

Kidney International

Volumn 64, Issue 4, 2003, Pages 1495-1504

  Prinsen, Berthil H C M T ^a   Rabelink, Ton J ^b   Beutler, Jaap J ^b   Kaysen, George A ^b   De Boer, Jose ^b   Boer, Walther H ^b   Hagen, E Christiaan ^b   Berger, Ruud ^b   De Sain Van Der Velden, Monique G M ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NONE

Author keywords

Albumin; Amino acids; Fibrinogen; Hyperfibrinogenemia; Hypoalbuminemia; Peritoneal dialysis; Renal failure

Indexed keywords

ALBUMIN; FIBRINOGEN;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBRINOGEN BLOOD LEVEL; FIBRINOGEN SYNTHESIS; HUMAN; HYPOALBUMINEMIA; INSULIN RESISTANCE; MALE; MALNUTRITION; METABOLIC ACIDOSIS; OBSERVATION; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROTEIN DEPLETION;

EID: 0141786799     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2003.00211.x     Document Type: Article

References (50)

1. MITTMAN N, AVRAM MM, OO KK, et al: Serum prealbumin predicts survival in hemodialysis and peritoneal dialysis: 10 years of prospective observation. Am J Kidney Dis 38:1358-1364, 2001
2. COLLINS AJ, LI S, MA JZ, et al: Cardiovascular disease in end-stage renal disease patients. Am J Kidney Dis 38:S26-S29, 2001
3. KESHAVIAH P, COLLINS AJ, MA JZ, et al: Survival comparison between hemodialysis and peritoneal dialysis based on matched doses of delivered therapy. J Am Soc Nephrol 13(Suppl 1):S48-S52, 2002
4. AVRAM MM, GOLDWASSER P, ERROA M, et al: Predictors of survival in continuous ambulatory peritoneal dialysis patients: The importance of prealbumin and other nutritional and metabolic markers. Am J Kidney Dis 23:91-98, 1994
5. YEUN JY, KAYSEN CA: Factors influencing serum albumin in dialysis patients. Am J Kidney Dis 32:S118-S125, 1998
6. MITCH WE: Insights into the abnormalities of chronic renal disease attributed to malnutrition. J Am Soc Nephrol 13(Suppl 1):S22-S27, 2002
7. YEUN JY, KAYSEN CA: Acute phase proteins and peritoneal dialysate albumin loss are the main determinants of serum albumin in peritoneal dialysis patients. Am J Kidney Dis 30:923-927, 1997
8. JUNGERS P, MASSY ZA, KHOA TN, et al: Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: A prospective study. Nephrol Dial Transplant 12:2597-2602, 1997
9. IRISH A: Cardiovascular disease, fibrinogen and the acute phase response: Associations with lipids and blood pressure in patients with chronic renal disease. Atherosclerosis 137:133-139, 1998
10. HEINRICH J, BALLEISEN L, SCHULTE H, et al: Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men. Arterioscler Thromb 14:54-59, 1994
11. KOCH M, KUTKUHN B, TRENKWALDER E, et al: Apolipoprotein B, fibrinogen, HDL cholesterol, and apolipoprotein(a) phenotypes predict coronary artery disease in hemodialysis patients. J Am Soc Nephrol 8:1889-1898, 1997
12. STENVINKEL P, HEIMBURGER O, PAULTRE F, et al: Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 55:1899-1911, 1999
13. KAYSEN CA, DUBIN JA, MULLER HG: The impact of albumin synthesis rate and the acute phase response in the dual regulation of fibrinogen levels in hemodialysis patients. Kidney Int 63:315-322, 2002
14. DE SAIN-VAN DER VELDEN MG, KAYSEN CA, DE MEER K, et al: Proportionate increase of fibrinogen and albumin synthesis in nephrotic patients: Measurements with stable isotopes. Kidney Int 53:181-188, 1998
15. ROCCHICCIOLI F, LEROUX JP, CARTIER P: Quantitation of 2-ketoacids in biological fluids by gas chromatography chemical ionization mass spectrometry of O-trimethylsilyl-quinoxalinol derivatives. Biomed Mass Spectrom 8:160-164, 1981
16. PRINSEN BH, DE SAIN-VAN DER VELDEN MG, KAYSEN GA, et al: Transferrin synthesis is increased in nephrotic patients insufficiently to replace urinary losses. J Am Soc Nephrol 12:1017-1025, 2001
17. VILA V, REGANON E, LLOPIS F, et al: A rapid method for isolation of fibrinogen from human plasma by precipitation with polyethylene glycol 6,000. Thromb Res 39:651-656, 1985
18. HILL RL: Hydrolysis of proteins. Adv Protein Chem 20:37-107, 1965
19. HUSEK P: Amino acid derivatization and analysis in five minutes. FEBS Lett 280:354-356, 1991
20. DE SAIN-VAN DER VELDEN MG, KAYSEN CA, BARRETT HA, et al: Increased VLDL in nephrotic patients results from a decreased catabolism while increased LDL results from increased synthesis. Kidney Int 53:994-1001, 1998
21. HURLEY PJ: Red cell and plasma volumes in normal adults. J Nucl Med 16:46-52, 1975
22. GIORDANO M, DE FEO P, LUCIDI P, et al: Increased albumin and fibrinogen synthesis in hemodialysis patients with normal nutritional status. J Am Soc Nephrol 12:349-354, 2001
23. KAYSEN CA, SCHOENFELD PY: Albumin homeostasis in patients undergoing continuous ambulatory peritoneal dialysis. Kidney Int 25:107-114, 1984
24. SAVDIE E, GIBSON JC, CRAWFORD CA, et al: Impaired plasma triglyceride clearance as a feature of both uremic and posttransplant triglyceridemia. Kidney Int 18:774-782, 1980
25. MAKRIS TK, STAVROULAKIS CA, KRESPI PC, et al: Fibrinolytic/hemostatic variables in arterial hypertension: Response to treatment with irbesartan or atenolol. Am J Hypertens 13:783-788, 2000
26. BHATIA J, MAHAJAN P, SIKKA M, et al: Effect of various antihypertensive drugs on plasma fibrinogen levels in patients with essential hypertension. Indian J Med Sci 55:491-494, 2001
27. DE SAIN-VAN DER VELDEN MG, REIJNGOUD DJ, KAYSEN CA, et al: Evidence for increased synthesis of lipoprotein(a) in the nephrotic syndrome. J Am Soc Nephrol 9:1474-1481, 1998
28. DE SAIN-VAN DER VELDEN MG, RABELINK TJ, REIJNGOUD DJ, et al: Plasma alpha 2 macroglobulin is increased in nephrotic patients as a result of increased synthesis alone. Kidney Int 54:530-535, 1998
29. KAYSEN GA, RATHORE V, SHEARER GC, et al: Mechanisms of hypoalbuminemia in hemodialysis patients. Kidney Int 48:510-516, 1995
30. KIRSCH R, FRITH L, BLACK E, et al: Regulation of albumin synthesis and catabolism by alteration of dietary protein. Nature 217:578-579, 1968
31. KAYSEN CA, STEVENSON FT, DEPNER TA: Determinants of albumin concentration in hemodialysis patients. Am J Kidney Dis 29:658-668, 1997
32. KAYSEN CA, CHERTOW GM, ADHIKARLA R, et al: Inflammation and dietary protein intake exert competing effects on serum albumin and creatinine in hemodialysis patients. Kidney Int 60:333-340, 2001
33. HAIDARI M, JAVADI E, SADEGHI B, et al: Evaluation of C-reactive protein, a sensitive marker of inflammation, as a risk factor for stable coronary artery disease. Clin Biochem 34:309-315, 2001
34. BALLMER PE, MCNURLAN MA, HULTER HN, et al: Chronic metabolic acidosis decreases albumin synthesis and induces negative nitrogen balance in humans. J Clin Invest 95:39-45, 1995
35. BRADY JP, HASBARGEN JA: Correction of metabolic acidosis and its effect on albumin in chronic hemodialysis patients. Am J Kidney Dis 31:35-40, 1998
36. ALVESTRAND A: Carbohydrate and insulin metabolism in renal failure. Kidney Int 52 (Suppl 62):S48-S52, 1997
37. DEFRONZO RA, ALVESTRAND A, SMITH D, et al: Insulin resistance in uremia. J Clin Invest 67:563-568, 1981
38. DE FEO P, GAISANO MG, HAYMOND MW: Differential effects of insulin deficiency on albumin and fibrinogen synthesis in humans. J Clin Invest 88:833-840, 1991
39. KAYSEN GA, WATSON JB: Mechanism of hypoalbuminemia in the 7/8-nephrectomized rat with chronic renal failure. Am J Physiol 243:F372-F378, 1982
40. KOPPLE JD, BLUMENKRANTZ MJ, JONES MR, et al: Plasma amino acid levels and amino acid losses during continuous ambulatory peritoneal dialysis. Am J Clin Nutr 36:395-402, 1982
41. RIEDEL E, HAMPL H, NUNDEL M, et al: Essential branched-chain amino acids and alpha-ketoanalogues in haemodialysis patients. Nephrol Dial Transplant 7:117-120, 1992
42. GARIBOTTO G, PAOLETII E, FIORINI F, et al: Peripheral metabolism of branched-chain keto acids in patients with chronic renal failure. Miner Electrolyte Metab 19:25-31, 1993
43. CUPISTI A, LANGER K, BARSOTTI G: Plasma levels of branched chain keto acids in nephrotic patients. Nephron 63:237, 1993
44. SWAIN LM, SHIOTA T, WALSER M: Utilization for protein synthesis of leucine and valine compared with their keto analogues. Am J Clin Nutr 51:411-415, 1990
45. KIRSCH RE, FRITH LO, SAUNDERS SJ: Stimulation of albumin synthesis by keto analogues of amino acids. Biochim Biophys Acta 442:437-441, 1976
46. MITCH WE, ABRAS E, WALSER M: Long-term effects of a new ketoacid-amino acid supplement in patients with chronic renal failure. Kidney Int 22:48-53, 1982
47. MARIANI G, BARSOTTI G, CIARDELLA F, et al: Albumin metabolism and nutritional status of uremic patients on a long-term very-low-protein diet supplemented with essential amino acids and keto analogues. J Nucl Med Allied Sci 28:237-244, 1984
48. NAVARRO JF, MORA C, LEON C, et al: Amino acid losses during hemodialysis with polyacrylonitrile membranes: Effect of intradialytic amino acid supplementation on plasma amino acid concentrations and nutritional variables in nondiabetic patients. Am J Clin Nutr 71:765-773, 2000
49. JONES M, HAGEN T, BOYLE CA, et al: Treatment of malnutrition with 1.1% amino acid peritoneal dialysis solution: Results of a multicenter outpatient study. Am J Kidney Dis 32:761-769, 1998
50. KOPPLE JD, BERNARD D, MESSANA J, et al: Treatment of malnourished CAPD patients with an amino acid based dialysate. Kidney Int 47:1148-1157, 1995